I believe that on July 10 the FDA will have reviewed the safety and manufacturing portions of the BLA. So on July 13, when the covid trial data is submitted to the FDA and the world, the only thing that will be remaining for the FDA to do in order to give Leronlimab covid approval will be to review that data. I love when things come together!